Personalising interventional therapy

Professor Dean Ho, Director of SINAPSE at NUS and recently elected Fellow of the prestigious US National Academy of Inventors, is focused on translating new technologies such as artificial intelligence into innovative interventional therapies that redefine the concept of 'personalised medicine' for patients around the world.

Read More

What it means to be human

Leaders from government agencies, academia, industry, media and civic society gathered from 27 to 28 November to discuss complex issues regarding human well-being and security in the third edition of the Raffles Dialogue.

Read More

Education Minister visits NUS Medicine

Minister for Education Ong Ye Kung paid a visit to NUS Medicine on 3 December. A discussion was held on the School’s undergraduate medical training strategies and research highlights with Dean Assoc Prof Yeoh Khay Guan and Vice-Dean (Education) Assoc Prof Lau Tang Ching.

Read More

Farewell to a jolly good fellow

Staff and students gathered for a light-hearted and rousing farewell to out-going Dean, Associate Professor Yeoh Khay Guan on 30 November 2018.

Read More

Ethical concerns over gene-editing

On November 26, Chinese scientist He Jiankui reported the historic live births of twin girls whose genes he had edited to include a variant protective against transmission of HIV. The move garnered negative reactions from both scientists and ethicists. Dr Owen Schaefer from NUS Medicine's Centre for Biomedical Ethics shares his views on the risky and reckless move.

Read More

Frailty tests for elderly at senior activity centres

In February 2019, a team of researchers from NUS and the Geriatric Education and Research Institute will seek to delay or reverse frailty in 300 seniors in the community. These seniors will undergo frailty screening at senior activity centres run by NTUC Health in Whampoa and Taman Jurong, and centres run by Presbyterian Community Services in Hougang and Tampines.

Read More

A potential new treatment method for melanoma skin cancer

Researchers at the National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine) have discovered a small man-made molecule that can activate a receptor in the cell membrane to “kill” tumour cells in melanoma skin cancer, controlling the growth of the cancer cells.

Read More